Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
21.3%
% of CANC's 47 holdings also in ARKG
30.3%
% of ARKG's 35 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus ARKG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in ARKG |
Overlap | |
|---|---|---|---|---|
 |
GUARDANT HEALTH, INC. | 2.6% | 4.5% | 2.6% |
|
CRISPR THERAPEUTICS AG | 2.3% | 6.9% | 2.3% |
|
SCHRODINGER, INC. | 2.0% | 4.1% | 2.0% |
|
AMGEN INC | 1.5% | 1.6% | 1.5% |
|
INTELLIA THERAPEUTICS, INC. | 1.5% | 3.2% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to ARKG
 |
ASTRAZENECA PLC | 5.6% |
|
GILEAD SCIENCES INC | 5.3% |
 |
ARGENX SE ADR | 4.6% |
|
BLUEPRINT MEDICINES CORP. | 4.6% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
|
REGENERON PHARMACEUTICALS | 4.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
EXELIXIS INC | 3.6% |
|
INCYTE CORP | 3.3% |
|
DAIICHI SANKYO CO LTD | 3.0% |
CANC Underweight Relative to ARKG
|
TWIST BIOSCIENCE CORP. | -9.2% |
|
RECURSION PHARMACEUTICALS, INC CLASS | -7.2% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -5.6% |
|
VERACYTE INC | -5.2% |
|
NATERA INC | -5.0% |
|
CAREDX, INC. | -4.9% |
|
CRISPR THERAPEUTICS AG | -4.6% |
|
BEAM THERAPEUTICS, INC. | -4.3% |
|
IONIS PHARMACEUTICALS, INC. | -3.9% |
|
10X GENOMICS INC CLASS A | -3.4% |